Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

Open access
Reynolds, Catherine J., Swadling, Leo, Gibbons, Joseph M., Pade, Corinna, Jensen, Melanie P., Diniz, Mariana O., Schmidt, Nathalie M., Butler, David K., Amin, Oliver E., Bailey, Sasha N. L., Murray, Sam M., Pieper, Franziska P., Taylor, Stephen, Jones, Jessica, Jones, Meleri, Lee, Wing-Yiu Jason, Rosenheim, Joshua, Chandran, Aneesh, Joy, George, Di Genova, Cecilia, Temperton, Nigel, Lambourne, Jonathan, Cutino-Moguel, Teresa, Andiapen, Mervyn, Fontana, Marianna, Smit, Angelique, Semper, Amanda, O’Brien, Ben, Chain, Benjamin, Brooks, Tim, Manisty, Charlotte, Treibel, Thomas, Moon, James C., COVIDsortium investigators, Noursadeghi, Mahdad, COVIDsortium immune correlates network, Altmann, Daniel M., Maini, Mala K., McKnight, Áine, Boyton, Rosemary J.·2020·Science Immunology

Abstract

Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2 is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody responses in 136 healthcare workers (HCW) 16-18 weeks after United Kingdom lockdown, 76 of whom had mild/asymptomatic SARS-CoV-2 infection captured by serial sampling. Neutralizing antibodies (nAb) were present in 89% of previously infected HCW. T cell responses tended to be lower following asymptomatic infection than in those reporting case-definition symptoms of COVID-19, while nAb titers were maintained irrespective of symptoms. T cell and antibody responses were sometimes discordant. Eleven percent lacked nAb and had undetectable T cell responses to spike protein but had T cells reactive with other SARS-CoV-2 antigens. Our findings suggest that the majority of individuals with mild or asymptomatic SARS-CoV-2 infection carry nAb complemented by multispecific T cell responses at 16-18 weeks after mild or asymptomatic SARS-CoV-2 infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciimmunol.abf3698

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 200

Metadata

Authors
Reynolds, C. J., Swadling, L., Gibbons, J. M., Pade, C., Jensen, M. P., Diniz, M. O., Schmidt, N. M., Butler, D. K., Amin, O. E., Bailey, S. N. L., Murray, S. M., Pieper, F. P., Taylor, S., Jones, J., Jones, M., Lee, W.-Y. J., Rosenheim, J., Chandran, A., Joy, G., Di Genova, C., Temperton, N., Lambourne, J., Cutino-Moguel, T., Andiapen, M., Fontana, M., Smit, A., Semper, A., O’Brien, B., Chain, B., Brooks, T., Manisty, C., Treibel, T., Moon, J. C., COVIDsortium investigators, Noursadeghi, M., COVIDsortium immune correlates network, Altmann, D. M., Maini, M. K., McKnight, Á., & Boyton, R. J.
Venue
Science Immunology
Published
2020-12-18
Volume
5
Issue
54
ISSN
2470-9468 (ISSN-L)
OpenAlex
W3114439193
Cited by
200
References
23
FWCI
5.22
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. https://app.cochat.ai/papers/10.1126/sciimmunol.abf3698
The paper
Reynolds, C. J., Swadling, L., Gibbons, J. M., Pade, C., Jensen, M. P., Diniz, M. O., Schmidt, N. M., Butler, D. K., Amin, O. E., Bailey, S. N. L., Murray, S. M., Pieper, F. P., Taylor, S., Jones, J., Jones, M., Lee, W.-Y. J., Rosenheim, J., Chandran, A., Joy, G., . . . Boyton, R. J. (2020). Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. Science Immunology. https://doi.org/10.1126/sciimmunol.abf3698

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.